Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06345404
Status:
RECRUITING
Last Update Posted:
2024-04-10
First Post:
2024-03-12
Brief Title:
Safety Tolerability and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
Sponsor:
Corvus Pharmaceuticals Inc
Organization:
Corvus Pharmaceuticals Inc
Organization Data
Organization:
Corvus Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
CPI-818-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Corvus Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None